Team OnMed is a group of dedicated business leaders and professionals. We are committed to help advanced oncology solutions to reach out globally.

Rude Klereby

Chairman, OnMed

Mr. Klereby is one of the co-founders of OnMed Oncology Medical Devices AB, and is its majority shareholder.

Thomas Warnke

CEO, OnMed and BionMed

Mr. Warnke studied Economics and European Law and graduated with a Magister degree. He went on to start BionMed Technologies GmbH in 1995. BionMed, based in Germany, is fully owned by OnMed AB, and manufactures the SENNEX® device. Together with Mr. Rude Klereby, Mr. Warnke founded  OnMedOncology Medical Devices AB in 2012.

Leif Rickardsson


Mr. Rickardsson has 25 years of experience in finance, accounting and administration in different companies and verticals of industry. In his earlier assignment, he held the post of a CFO in the corporate group Travel Invest JAB AB.

Tommy Hiller

International Sales Director

Starting out working in management assignments within the UN in Cyprus and Middle East, Mr. Hiller went on to work as a commercial pilot. He later took up network management, and gained 30 years of experience as a senior manager in the telecom business, working both nationally and internationally. 

Dr. Ulrich Warnke

Expert Physiologist and Inventor of SENNEX®

Dr. Warnke is the inventor of the SENNEX® machine. Previously worked as Academic Senior Counselor at the University of Saarland,  Departments of Biology and Physics. He is now active within OnMed’s scientific research department.

Björn Lindroth

Legal Advisor, CrusnerAdvokatbyrå

Mr. Lindroth is the legal advisor of OnMed AB and currently works at Crusner Law firm. His specializations are in Contract Law, Obligation Law, Corporate Law and Insurance Law. He graduated with a bachelor’s degree in Law from Stockholm University in 1994.

Dr. Ali A.Mohamedi


With 20 years of international experience in the medical device and pharmaceuticals industry, Dr. Ali has been specifically trained for electrochemotherapy treatment of cancer. He is a healthcare sector influencer and acts as our global point of contact for clinical enquiries, hospital and clinics.